Similar articles

• Blocking CD27-CD70 costimulatory pathway suppresses experimental colitis.

  Manocha M, Rietdijk S, Laouar A, Liao G, Bhan A, Borst J, Terhorst C, Manjunath N. Manocha M, et al. J Immunol. 2009 Jul 1;183(1):270-6. doi: 10.4049/jimmunol.0802424. Epub 2009 Jun 12. J Immunol. 2009. PMID: 19525396 Free PMC article.
• CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia.

  Riether C, Schürch CM, Bührer ED, Hinterbrandner M, Huguenin AL, Hoepner S, Zlobec I, Pabst T, Radpour R, Ochsenbein AF. Riether C, et al. J Exp Med. 2017 Feb;214(2):359-380. doi: 10.1084/jem.20152008. Epub 2016 Dec 28. J Exp Med. 2017. PMID: 28031480 Free PMC article.
• Blockade of costimulatory CD27/CD70 pathway promotes corneal allograft survival.

  Narimatsu A, Hattori T, Usui Y, Ueno H, Funaki T, Komatsu H, Nakagawa H, Akiba H, Goto H. Narimatsu A, et al. Exp Eye Res. 2020 Oct;199:108190. doi: 10.1016/j.exer.2020.108190. Epub 2020 Aug 14. Exp Eye Res. 2020. PMID: 32798537
• Monoclonal Antibodies for Multiple Sclerosis Treatment.

  Palavra F. Palavra F. Acta Med Port. 2015 Sep-Oct;28(5):640-51. doi: 10.20344/amp.6486. Epub 2015 Oct 30. Acta Med Port. 2015. PMID: 26667869 Review.
• Natalizumab and other monoclonal antibodies.

  Ursell MR, O'Connor PW. Ursell MR, et al. Neurol Clin. 2005 Feb;23(1):233-46, viii. doi: 10.1016/j.ncl.2004.09.005. Neurol Clin. 2005. PMID: 15661096 Review. No abstract available.